Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8209)
All Articles published online
|
Publishing Process of This Article
|
Feb 28, 2014 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guo Z, Li LQ, Jiang JH, Ou C, Zeng LX, Xiang BD. Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma. World J Gastroenterol 2014; 20(8): 2098-2106 [PMID: 24616575 DOI: 10.3748/wjg.v20.i8.2098] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i8/2098.htm |
| Number | Citing Articles |
| 1 |
Asmaa G. Abdou, Nanis S. Holah, Dina S. Elazab, Walaa G. El-Gendy, Mohammed T. Badr, Dalia R. Al-Sharaky. Hepatocellular Carcinoma Score and Subclassification Into Aggressive Subtypes Using Immunohistochemical Expression of p53, β-Catenin, CD133, and Ki-67. Applied Immunohistochemistry & Molecular Morphology 2021; 29(1): 20 doi: 10.1097/PAI.0000000000000840
|
| 2 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_1-1
|
| 3 |
Mona Y.Y. Abd Allah, Amro R.A. El-Karef, Waleed A. Askar. Expression of CD90 as a stem cell marker in hepatocarcinogenesis. Egyptian Journal of Pathology 2018; 38(1): 6 doi: 10.1097/01.XEJ.0000534710.66241.04
|
| 4 |
Ryouichi Tsunedomi, Kiyoshi Yoshimura, Nobuaki Suzuki, Shoichi Hazama, Hiroaki Nagano. Clinical implications of cancer stem cells in digestive cancers: acquisition of stemness and prognostic impact. Surgery Today 2020; 50(12): 1560 doi: 10.1007/s00595-020-01968-x
|
| 5 |
Yu-Chin Liu, Chau-Ting Yeh, Kwang-Huei Lin. Cancer Stem Cell Functions in Hepatocellular Carcinoma and Comprehensive Therapeutic Strategies. Cells 2020; 9(6): 1331 doi: 10.3390/cells9061331
|
| 6 |
Tao Wang, Xingyue Liu, Xuetong Qu, Yuexin Li, Xiao Liang, Jianmin Wu. Lipid response of hepatocellular carcinoma cells to anticancer drug detected on nanostructure-assisted LDI-MS platform. Talanta 2021; 235: 122817 doi: 10.1016/j.talanta.2021.122817
|
| 7 |
Y.S. Kim, A.M. Kaidina, J.H. Chiang, K.N. Yarygin, A.Yu. Lupatov. Molecular markers of cancer stem cells verified in vivo. Biomeditsinskaya Khimiya 2016; 62(3): 228 doi: 10.18097/PBMC20166203228
|
| 8 |
Naoto Koike. Stem Cells and Cancer in Hepatology. 2018; : 211 doi: 10.1016/B978-0-12-812301-0.00011-6
|
| 9 |
Linhua Zhou, Yanping Zhu. The EpCAM overexpression is associated with clinicopathological significance and prognosis in hepatocellular carcinoma patients: A systematic review and meta-analysis. International Journal of Surgery 2018; 56: 274 doi: 10.1016/j.ijsu.2018.06.025
|
| 10 |
ZHE GUO, JING-HANG JIANG, JUN ZHANG, HAO-JIE YANG, YAN-PING ZHONG, JIE SU, RI-RONG YANG, LE-QUN LI, BANG-DE XIANG. Side population in hepatocellular carcinoma HCCLM3 cells is enriched with stem-like cancer cells. Oncology Letters 2016; 11(5): 3145 doi: 10.3892/ol.2016.4343
|
| 11 |
Rui Caetano Oliveira, Ricardo Martins, Ana Margarida Abrantes, Ângela Jesus, Paulo Teixeira, Carolina Canhoto, Pedro Guerreiro, Beatriz Costa, Mário Rui Silva, José Guilherme Tralhão, Maria Augusta Cipriano. Morphophenotypic Classification of Hepatocellular Carcinoma: the Biliary/Stem Cell Subgroup and Worst Outcome—Implications on Patient Selection. Journal of Gastrointestinal Surgery 2021; 25(3): 698 doi: 10.1007/s11605-020-04611-9
|
| 12 |
Marianna B. Ruzinova, Changqing Ma, Elizabeth M. Brunt, Charles W. Goss, Neeta Vachharajani, William C. Chapman, Ta-Chiang Liu. SOX9 Expression Is Superior to Other Stem Cell Markers K19 and EpCAM in Predicting Prognosis in Hepatocellular Carcinoma. American Journal of Surgical Pathology 2023; 47(1): 1 doi: 10.1097/PAS.0000000000001990
|
| 13 |
Alastair D Burt, Venâncio Alves, Pierre Bedossa, Andrew Clouston, Maria Guido, Stefan Hübscher, Sanjay Kakar, Irene Ng, Young N Park, Helen Reeves, Judith Wyatt, Matthew M Yeh, David W Ellis. Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR). Histopathology 2018; 73(3): 369 doi: 10.1111/his.13520
|
| 14 |
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival. World Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
|
| 15 |
Xue Wen, Sunbin Ling, Weiqiang Wu, Qiaonan Shan, Peng Liu, Chao Wang, Xuyong Wei, Wei Ding, Xiaodong Teng, Xiao Xu. Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma. Digestive Diseases and Sciences 2020; 65(4): 1064 doi: 10.1007/s10620-019-05844-8
|
| 16 |
Leonardo do Prado Lima, Carla Jorge Machado, João Bernardo Sancio Rocha Rodrigues, Leonardo de Souza Vasconcellos, Eduardo Paulino Junior, Paula Vieira Teixeira Vidigal, Vivian Resende. Immunohistochemical Coexpression of Epithelial Cell Adhesion Molecule and Alpha-Fetoprotein in Hepatocellular Carcinoma. Canadian Journal of Gastroenterology and Hepatology 2018; 2018: 1 doi: 10.1155/2018/5970852
|
| 17 |
Min Ding, Jiang Li, Yong Yu, Hui Liu, Zi Yan, Jinghan Wang, Qijun Qian. Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells. Journal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0609-7
|
| 18 |
Annie R.A. McDougall, Mary Tolcos, Stuart B. Hooper, Timothy J. Cole, Megan J. Wallace. Trop2: From development to disease. Developmental Dynamics 2015; 244(2): 99 doi: 10.1002/dvdy.24242
|
| 19 |
Hend Ibrahim Shousha, Rabab Fouad, Tamer Mahmoud Elbaz, Dina Sabry, Mohamed Mahmoud Nabeel, Ahmed Hosni Abdelmaksoud, Aisha Mahmoud Elsharkawy, Zeinab Abdellatif Soliman, Ghada Habib, Ashraf Omar Abdelaziz. Predictors of recurrence and survival of hepatocellular carcinoma: A prospective study including transient elastography and cancer stem cell markers. Arab Journal of Gastroenterology 2020; 21(2): 95 doi: 10.1016/j.ajg.2020.04.002
|
| 20 |
Rui Yang, Li Y. An, Qin F. Miao, Feng M. Li, Yong Han, Hui X. Wang, Dang P. Liu, Rong Chen, Sha Q. Tang. Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes. Oncotarget 2016; 7(24): 35894 doi: 10.18632/oncotarget.9116
|
| 21 |
Ji Hae Nahm, Hyungjin Rhee, Haeryoung Kim, Jeong Eun Yoo, Jee San Lee, Youngsic Jeon, Gi Hong Choi, Young Nyun Park. Increased expression of stemness markers and altered tumor stroma in hepatocellular carcinoma under TACE-induced hypoxia: A biopsy and resection matched study. Oncotarget 2017; 8(59): 99359 doi: 10.18632/oncotarget.22078
|
| 22 |
Philipp Heumann, Andreas Albert, Karsten Gülow, Deniz Tümen, Martina Müller, Arne Kandulski. Insights in Molecular Therapies for Hepatocellular Carcinoma. Cancers 2024; 16(10): 1831 doi: 10.3390/cancers16101831
|
| 23 |
Jun Liu, Jianjun Lu, Wenli Li, Cinzia Allegrucci. A Comprehensive Prognostic and Immunological Analysis of a New Three-Gene Signature in Hepatocellular Carcinoma. Stem Cells International 2021; 2021: 1 doi: 10.1155/2021/5546032
|
| 24 |
Yan Li, Weizhong Zhang, Anne Doughtie, Guozhen Cui, Xuanyi Li, Harshul Pandit, Yingbin Yang, Suping Li, Robert Martin. Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma. Oncotarget 2016; 7(32): 52329 doi: 10.18632/oncotarget.10750
|
| 25 |
Brian I. Carr, Vito Guerra, Volkan Ince, Burak Isik, Sezai Yilmaz. Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level. Liver Research 2023; 7(3): 256 doi: 10.1016/j.livres.2023.07.003
|
| 26 |
Chen Zhong, Jin-Dao Wu, Ming-Ming Fang, Li-Yong Pu. Clinicopathological significance and prognostic value of the expression of the cancer stem cell marker CD133 in hepatocellular carcinoma: a meta-analysis. Tumor Biology 2015; 36(10): 7623 doi: 10.1007/s13277-015-3487-y
|
| 27 |
Yu-Chong Peng, Shi-Dong Lu, Jian-Hong Zhong, Zhi-Bo Xie, Xue-Mei You, Ning-Fu Peng, Le-Qun Li. Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity. Tumor Biology 2016; 37(8): 10943 doi: 10.1007/s13277-016-4915-3
|
| 28 |
Chun-Chieh Yeh, Pei-Ying Liao, Sudhir Pandey, Su-Yung Yung, Hsueh-Chou Lai, Long-Bin Jeng, Wei-Chun Chang, Wen-Lung Ma. Metronomic Celecoxib Therapy in Clinically Available Dosage Ablates Hepatocellular Carcinoma via Suppressing Cell Invasion, Growth, and Stemness in Pre-Clinical Models. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.572861
|
| 29 |
LI ZHANG, CUIJU WANG, SHUFENG LIU, YUFEI ZHAO, CHAO LIU, ZHANJUN GUO. Prognostic significance of Dicer expression in hepatocellular carcinoma. Oncology Letters 2016; 11(6): 3961 doi: 10.3892/ol.2016.4547
|
| 30 |
Yi‐Nan Shen, Hai‐Guan He, Yang Shi, Jian Cao, Jian‐Yong Yuan, Zhou‐Chong Wang, Chun‐Feng Shi, Nan Zhu, Yong‐Peng Wei, Fang Liu, Jia‐Li Huang, Guang‐Shun Yang, Jun‐Hua Lu. Krüppel‐like factor 8 promotes cancer stem cell‐like traits in hepatocellular carcinoma through Wnt/β‐catenin signaling. Molecular Carcinogenesis 2017; 56(2): 751 doi: 10.1002/mc.22532
|
| 31 |
Hang-Lung Chang, Oluwaseun Adebayo Bamodu, Jiann-Ruey Ong, Wei-Hwa Lee, Chi-Tai Yeh, Jo-Ting Tsai. Targeting the Epigenetic Non-Coding RNA MALAT1/Wnt Signaling Axis as a Therapeutic Approach to Suppress Stemness and Metastasis in Hepatocellular Carcinoma. Cells 2020; 9(4): 1020 doi: 10.3390/cells9041020
|
| 32 |
Kuo-Shyang Jeng, Chiung-Fang Chang, I-Shyang Sheen, Chi-Juei Jeng, Chih-Hsuan Wang. Cellular and Molecular Biology of Cancer Stem Cells of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2023; 24(2): 1417 doi: 10.3390/ijms24021417
|
| 33 |
Hamed Hemati, Jagdeep Kaur, R.C. Sobti, Nirupma Trehanpati. Inhibition of NOTCH signaling pathway chemosensitizes HCC CD133+ cells to vincristine and 5-fluorouracil through upregulation of BBC3. Biochemical and Biophysical Research Communications 2020; 525(4): 941 doi: 10.1016/j.bbrc.2020.03.009
|
| 34 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 293 doi: 10.1007/978-3-319-26956-6_14
|
| 35 |
Qie Guo, Xiao Li, Meng-Na Cui, Jia-Lin Sun, Hong-Yan Ji, Bei-Bei Ni, Mei-Xing Yan. CD13: A Key Player in Multidrug Resistance in Cancer Chemotherapy. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2020; 28(5): 533 doi: 10.3727/096504020X15919605976853
|
| 36 |
Leila Valanejad, Kyle Lewis, Mary Wright, Yanjun Jiang, Amber D’Souza, Rebekah Karns, Rachel Sheridan, Anita Gupta, Kevin Bove, David Witte, James Geller, Gregory Tiao, David L. Nelson, Lubov Timchenko, Nikolai Timchenko. FXR-Gankyrin axis is involved in development of pediatric liver cancer. Carcinogenesis 2017; 38(7): 738 doi: 10.1093/carcin/bgx050
|
| 37 |
Chihiro Yamanaka, Hiroshi Wada, Hidetoshi Eguchi, Hisanori Hatano, Kunihito Gotoh, Takehiro Noda, Daisaku Yamada, Tadafumi Asaoka, Koichi Kawamoto, Hiroaki Nagano, Yuichiro Doki, Masaki Mori. Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma. Japanese Journal of Clinical Oncology 2018; 48(1): 52 doi: 10.1093/jjco/hyx157
|
| 38 |
An B. Luong, Huy Q. Do, Paola Tarchi, Deborah Bonazza, Cristina Bottin, Loraine Kay D. Cabral, Long D. C. Tran, Thao P. T. Doan, Lory S. Crocè, Hoa L. T. Pham, Claudio Tiribelli, Caecilia H. C. Sukowati. The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations. Cells 2020; 9(12): 2672 doi: 10.3390/cells9122672
|
| 39 |
Xiaolei Zhang, Shuang Liu, Congle Shen, Yali Wu, Ling Zhang, Xiangmei Chen, Fengmin Lu. DNA Methylation Consistency Implicates the Primary Tumor Cell Origin of Recurrent Hepatocellular Carcinoma. Epigenomics 2015; 7(4): 581 doi: 10.2217/epi.15.23
|
| 40 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_14-1
|
| 41 |
Georgia-Persephoni Voulgaridou, Magdalini Kiziridou, Theodora Mantso, Katerina Chlichlia, Alex Galanis, Michael I. Koukourakis, Rodrigo Franco, Mihalis I. Panayiotidis, Aglaia Pappa. Aldehyde dehydrogenase 3A1 promotes multi-modality resistance and alters gene expression profile in human breast adenocarcinoma MCF-7 cells. The International Journal of Biochemistry & Cell Biology 2016; 77: 120 doi: 10.1016/j.biocel.2016.06.004
|
| 42 |
Bruno Christian Köhler, Nina Waldburger, Kai Schlamp, Dirk Jäger, Karl Heinz Weiss, Henning Schulze-Bergkamen, Peter Schirmacher, Christoph Springfeld. Liver cancers with stem/progenitor-cell features - a rare chemotherapy-sensitive malignancy. Oncotarget 2017; 8(35): 59991 doi: 10.18632/oncotarget.19000
|
| 43 |
Asmaa M. Zahran, Mona H. Abdel-Rahim, Ahmed Refaat, Mona Sayed, Mostafa M. Othman, Lamiaa M. R. Khalak, Helal F. Hetta. Circulating hematopoietic stem cells, endothelial progenitor cells and cancer stem cells in hepatocellular carcinoma patients: contribution to diagnosis and prognosis. Acta Oncologica 2020; 59(1): 33 doi: 10.1080/0284186X.2019.1657940
|
| 44 |
Hongzhi Liu, Yingchao Wang, Xiaohua Xing, Ying Sun, Dahai Wei, Geng Chen, Qinying Liu, Shanshan Chen, Xiaolong Liu, Jingfeng Liu. Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials. Oncology Letters 2018; doi: 10.3892/ol.2018.8666
|
| 45 |
Zhe Guo, Jing-Hang Jiang, Jun Zhang, Hao-Jie Yang, Fu-Quan Yang, Ya-Peng Qi, Yan-Ping Zhong, Jie Su, Ri-Rong Yang, Le-Qun Li, Bang-De Xiang. COX-2 Promotes Migration and Invasion by the Side Population of Cancer Stem Cell-Like Hepatocellular Carcinoma Cells. Medicine 2015; 94(44): e1806 doi: 10.1097/MD.0000000000001806
|
| 46 |
Tony El Jabbour, Stephen M Lagana, Hwajeong Lee. Update on hepatocellular carcinoma: Pathologists’ review. World Journal of Gastroenterology 2019; 25(14): 1653-1665 doi: 10.3748/wjg.v25.i14.1653
|
| 47 |
Archana Rastogi. Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(35): 4000-4013 doi: 10.3748/wjg.v24.i35.4000
|
| 48 |
Qian Zhang, Wanting Xing, Jie Zhang, Junwen Hu, Lunan Qi, Bangde Xiang. Circulating Tumor Cells Undergoing the Epithelial–Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma. OncoTargets and Therapy 2021; : 1543 doi: 10.2147/OTT.S298576
|
| 49 |
Zhouhong Ge, Jean C.A. Helmijr, Maurice P.H.M. Jansen, Patrick P.C. Boor, Lisanne Noordam, Maikel Peppelenbosch, Jaap Kwekkeboom, Jaco Kraan, Dave Sprengers. Detection of oncogenic mutations in paired circulating tumor DNA and circulating tumor cells in patients with hepatocellular carcinoma. Translational Oncology 2021; 14(7): 101073 doi: 10.1016/j.tranon.2021.101073
|
| 50 |
Peiwen Ding, Panyu Chen, Jiqi Ouyang, Qiang Li, Shijie Li. Clinicopathological and prognostic value of epithelial cell adhesion molecule in solid tumours: a meta-analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1242231
|
| 51 |
Izabela Zarębska, Arkadiusz Gzil, Justyna Durślewicz, Damian Jaworski, Paulina Antosik, Navid Ahmadi, Marta Smolińska-Świtała, Dariusz Grzanka, Łukasz Szylberg. The clinical, prognostic and therapeutic significance of liver cancer stem cells and their markers. Clinics and Research in Hepatology and Gastroenterology 2021; 45(3): 101664 doi: 10.1016/j.clinre.2021.101664
|
| 52 |
Maurizio Romano, Francesco De Francesco, Giuseppe Pirozzi, Enrico Gringeri, Riccardo Boetto, Marina Di Domenico, Barbara Zavan, Giuseppe A. Ferraro, Umberto Cillo. Expression of cancer stem cell biomarkers as a tool for a correct therapeutic approach to hepatocellular carcinoma. Oncoscience 2015; 2(5): 443 doi: 10.18632/oncoscience.163
|
| 53 |
Kandasamy Ashokachakkaravarthy, Biju Pottakkat. Mitotic quiescence in hepatic cancer stem cells: An incognito mode. Oncology Reviews 2020; 14(1) doi: 10.4081/oncol.2020.452
|
| 54 |
Valery Vilchez, Lilia Turcios, Yekaterina Zaytseva, Rachel Stewart, Eun Y. Lee, Erin Maynard, Malay B. Shah, Michael F. Daily, Ching-Wei D. Tzeng, Daniel Davenport, Ana Lia Castellanos, Steven Krohmer, Peter J. Hosein, Bernard Mark Evers, Roberto Gedaly. Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma. The American Journal of Surgery 2016; 212(2): 238 doi: 10.1016/j.amjsurg.2015.12.019
|
| 55 |
S M Kessler, S Laggai, A Barghash, C S Schultheiss, E Lederer, M Artl, V Helms, J Haybaeck, A K Kiemer. IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype. Cell Death & Disease 2015; 6(10): e1894 doi: 10.1038/cddis.2015.241
|
| 56 |
Sanjit K. Roy, Shivam Srivastava, Caroline McCance, Anju Shrivastava, Jason Morvant, Sharmila Shankar, Rakesh K. Srivastava. Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2024; 28(9) doi: 10.1111/jcmm.18295
|
| 57 |
Duurenjargal Tseeleesuren, Hui-Hua Hsiao, Rajni Kant, Yu-Chuen Huang, Hung-Pin Tu, Chih-Chung Lai, Shiu-Feng Huang, Chia-Hung Yen. The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma. Medicina 2022; 58(2): 212 doi: 10.3390/medicina58020212
|
| 58 |
Jinghang Jiang, Peipei Yang, Zhe Guo, Rirong Yang, Haojie Yang, Fuquan Yang, Lequn Li, Bangde Xiang. Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line. World Journal of Surgical Oncology 2016; 14(1) doi: 10.1186/s12957-016-1028-9
|
| 59 |
Bo Hyun Kim, Joong-Won Park, Jin Sook Kim, Sook-Kyung Lee, Eun Kyung Hong. Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma. Gut and Liver 2019; 13(3): 342 doi: 10.5009/gnl18345
|
| 60 |
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, Ning Wang, Yibin Feng. The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma. Medicinal Research Reviews 2023; 43(6): 1946 doi: 10.1002/med.21967
|
| 61 |
Cheng-Pei Zhu, An-Qiang Wang, Hao-Hai Zhang, Xue-Shuai Wan, Xiao-Bo Yang, Shu-Guang Chen, Hai-Tao Zhao. Research progress and prospects of markers for liver cancer stem cells. World Journal of Gastroenterology 2015; 21(42): 12190-12196 doi: 10.3748/wjg.v21.i42.12190
|
| 62 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3 doi: 10.1007/978-3-319-26956-6_1
|
| 63 |
Sureerat Padthaisong, Malinee Thanee, Nisana Namwat, Jutarop Phetcharaburanin, Poramate Klanrit, Narong Khuntikeo, Attapol Titapun, Sakkarn Sungkhamanon, Hideyuki Saya, Watcharin Loilome. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02243-w
|
| 64 |
Zhitong Wu, Qinghai Zeng, Ke Cao, Yifan Sun. Exosomes: small vesicles with big roles in hepatocellular carcinoma. Oncotarget 2016; 7(37): 60687 doi: 10.18632/oncotarget.10807
|
| 65 |
Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang, Yen-Hua Huang. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1442-2
|
| 66 |
Rui Liu, Yuan Shen, Kejun Nan, Baibing Mi, Tao Wu, Jinyue Guo, Miaojing Li, Yi Lv, Hui Guo. Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma. Medicine 2015; 94(31): e1306 doi: 10.1097/MD.0000000000001306
|
| 67 |
Alice Conigliaro, Viviana Costa, Alessia Lo Dico, Laura Saieva, Simona Buccheri, Francesco Dieli, Mauro Manno, Samuele Raccosta, Carmine Mancone, Marco Tripodi, Giacomo De Leo, Riccardo Alessandro. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA. Molecular Cancer 2015; 14(1) doi: 10.1186/s12943-015-0426-x
|
| 68 |
Amedeo Carraro, Elisabetta Trevellin, Matteo Fassan, Andromachi Kotsafti, Francesca Lunardi, Andrea Porzionato, Luigi Dall'Olmo, Matteo Cagol, Rita Alfieri, Veronica Macchi, Umberto Tedeschi, Fiorella Calabrese, Massimo Rugge, Carlo Castoro, Roberto Vettor, Marco Scarpa. Esophageal adenocarcinoma microenvironment: Peritumoral adipose tissue effects associated with chemoresistance. Cancer Science 2017; 108(12): 2393 doi: 10.1111/cas.13415
|
| 69 |
Y. S. Kim, A. M. Kaidina, J.-H. Chiang, K. N. Yarygin, A. Yu. Lupatov. Cancer stem cell molecular markers verified in vivo. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 2017; 11(1): 43 doi: 10.1134/S1990750817010036
|
| 70 |
Dashuai Yang, Ying Hu, Junfa Yang, Liangsong Tao, Yue Su, Yincui Wu, Yan Yao, Shuxian Wang, Sheng Ye, Tao Xu. Research Progress on the Correlation between Acetaldehyde Dehydrogenase 2 and Hepatocellular Carcinoma Development. The Journal of Pharmacology and Experimental Therapeutics 2024; 389(2): 163 doi: 10.1124/jpet.123.001898
|